| Literature DB >> 30184104 |
Monica Gandhi1, Peter Bacchetti2, Igho Ofokotun3, Chengshi Jin2, Heather J Ribaudo4, David W Haas5,6, Anandi N Sheth3, Howard Horng1, Nhi Phung1, Karen Kuncze1, Hideaki Okochi7, Raphael J Landovitz8, Jeffrey Lennox3, Judith S Currier8.
Abstract
Concentrations of antiretrovirals in hair are associated with virologic outcomes in cohorts of human immunodeficiency virus (HIV)-positive individuals but have never been examined in a clinical trial. We show for the first time the predictive utility of hair antiretroviral concentrations in a large HIV treatment-naive trial (AIDS Clinical Trials Group protocol A5257).Entities:
Keywords: A5257 study; AIDS Clinical Trials Group (ACTG); HIV; hair concentrations; non-NNRTI regimens
Mesh:
Substances:
Year: 2019 PMID: 30184104 PMCID: PMC6399433 DOI: 10.1093/cid/ciy764
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079